In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to ...

French clinical-stage biotechnology and microbiome therapy company MaaT Pharma has seen success with its Phase III trial of MaaT013 meeting its primary endpoints, leading to a jump in the company ...

MaaT Pharma – Investor Relations Guilhaume DEBROAS, Ph.D. Head of Investor Relations +33 6 16 48 92 50 invest@maat-pharma.com MaaT Pharma – Media Relations Pauline RICHAUD Senior PR ...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

MaaT Pharma has observed a 75% increase in physician demand with MaaT013 under the ongoing EAP in 2024 compared to 2023, across Europe and, more recently, in the United States.

IFC Films, the studio behind “Late Night With the Devil” and “Memoir of a Snail,” has tapped Ayo Kepher-Maat as its new vice president of acquisitions and productions.In this new role ...

Kepher-Maat also gives New York-based IFC an additional presence in LA, he noted. Last year across the labels were 30 Shudder movies, 12 IFC Films and eight RLJE, not all released theatrically.

In Bates’ new role as Coordinator, she will be responsible for scouting and identifying talent to sign at the company. Bates began working at Strig Artist Management as an assistant in May 2024.

Libertarian Vice Presidential candidate Mike ter Maat says old habits die hard and he expects more interest following the first Presidential debate. Skip Navigation. Share on Facebook; ...